Trinity Capital committed $40 million in term loans to Taysha Gene Therapies, a clinical-stage gene therapy company, pursuant to a loan and security agreement by and among Taysha, the lenders party thereto and Trinity as administrative agent and collateral agent for the lenders.
SetPoint Medical, a clinical-stage healthcare company dedicated to patients with chronic autoimmune diseases, entered into a senior secured term loan facility of up to $65 million from Runway Growth Capital, a provider of growth loans to both venture and non-venture backed companies.
Runway Growth Capital closed a senior secured term loan of $45 million to Nalu Medical, a privately held medical device company focused on innovative and minimally invasive solutions for chronic neuropathic pain.
TRACON Pharmaceuticals, a clinical stage biopharmaceutical company, entered into a $35 million non-dilutive long-term debt facility with Runway Growth Capital.
Runway Growth Capital closed a senior secured term loan of $25 million to Revelle Aesthetics, a developer of novel medical devices for aesthetic needs.
Mustang Bio completed a $75 million long-term debt facility with Runway Growth Capital, with $30 million of the $75 million loan funded upon closing.
Runway Growth Capital hired Igor DaCruz as managing director to continue to expand the company’s life sciences origination team. Prior to Runway, DaCruz worked as the director of life sciences for the Southwest region for Silicon Valley Bank.
Silicon Valley Bank replaced HTG Molecular Diagnostics’ existing senior credit facility with a $10 million senior term loan agreement.